| CLASS | ABXBACT | LP7755-4 |
| COMPONENT | Spiramycin | LP16414-2 |
| PROPERTY | Susc | LP6870-2 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Isolate | LP7370-2 |
| SCALE_TYP | Qn | LP7753-9 |
| METHOD_TYP | MLC | LP6402-4 |
| parent | Spiramycin | Isolate | Antibiotic susceptibilities | LP380881-5 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Observation | |
| UNITSREQUIRED | Y | |
| STATUS | ACTIVE |
| LONG_COMMON_NAME | en-US | Spiramycin [Susceptibility] by Minimum lethal concentration (MLC) |
| LONG_COMMON_NAME | en-US | Spiramycin [Susceptibility] by Minimum lethal concentration (MLC) |
| SHORTNAME | en-US | Spiramycin Islt MLC |
| ConsumerName | en-US | Susceptibility to Spiramycin |
| SHORTNAME | es-AR | espiramicina:susceptibilidad:punto en el tiempo:cepa clínica:cuantitativo:concentración letal mínima |
| SHORTNAME | pt-BR | Spiramycin Islt MLC |
| LONG_COMMON_NAME | de-DE | Spiramycin [Empfindlichkeit] mittels Bestimmung der minimalen letalen Konzentration (MLK) |
| LONG_COMMON_NAME | fr-FR | Spiramycine [Sensibilité] Isolat ; Numérique ; Concentration minimale létale |
| LONG_COMMON_NAME | nl-NL | Spiramycine [gevoeligheid] in isolaat d.m.v. minimaal dodelijke concentratie |
| LONG_COMMON_NAME | es-MX | Espiramicina: Aislado : Punto temporal: Susceptibilidad (microorganismos): Cuantitativo: Concentración mínima letal (MLC) |
LOINC Version: 2.81
FHIR